Dow Down 0.25% Nasdaq Down 0.26%

Gilead Sciences Inc. (GILD)

-NasdaqGS
107.51 Up 0.10(0.09%) 4:00PM EDT
|After Hours : 107.86 Up 0.35 (0.33%) 7:58PM EDT - Nasdaq Real Time Price
Prev Close:107.41
Open:107.00
Bid:107.62 x 300
Ask:107.90 x 300
1y Target Est:112.00
Beta:0.95
Earnings Date:Oct 27 - Oct 31 (Est.)
Day's Range:106.74 - 108.11
52wk Range:58.81 - 108.77
Volume:10,306,375
Avg Vol (3m):11,884,900
Market Cap:162.52B
P/E (ttm):39.82
EPS (ttm):2.70
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
GILDUp 0.09%162.52B
GSKUp 0.41%117.39B
PFEDown 0.37%186.29B
RHHBYDown 0.19%248.42B

Key Statistics

Forward P/E (1 yr):11.50
P/S (ttm):9.31
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :8.00
Quarterly EPS Est (Sep-14) :1.89
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):0.54

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines for the treatment of life threatening diseases in North America, South America, Europe, and the Asia-Pacific. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback